At the time of writing, ANI Pharmaceuticals Inc [ANIP] stock is trading at $66.6, up 4.06%. An important factor to consider is whether the stock is rising or falling in short-term value. The ANIP shares have gain 1.98% over the last week, with a monthly amount glided 6.46%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
ANI Pharmaceuticals Inc [NASDAQ: ANIP] stock has seen the most recent analyst activity on July 10, 2025, when H.C. Wainwright initiated its Buy rating and assigned the stock a price target of $84. Previously, Jefferies started tracking the stock with Buy rating on March 14, 2025, and set its price target to $80. On March 12, 2025, JP Morgan initiated with a Overweight rating and assigned a price target of $85 on the stock. Leerink Partners started tracking the stock assigning a Outperform rating and suggested a price target of $80 on December 11, 2024. Piper Sandler initiated its recommendation with a Overweight and recommended $68 as its price target on October 11, 2024. CapitalOne started tracking with a Overweight rating for this stock on March 15, 2024, and assigned it a price target of $80. In a note dated August 22, 2023, H.C. Wainwright reiterated an Buy rating on this stock and boosted its target price from $60 to $73.
For the past year, the stock price of ANI Pharmaceuticals Inc fluctuated between $52.50 and $77.00. Currently, Wall Street analysts expect the stock to reach $86 within the next 12 months. ANI Pharmaceuticals Inc [NASDAQ: ANIP] shares were valued at $66.6 at the most recent close of the market. An investor can expect a potential return of 29.13% based on the average ANIP price forecast.
Analyzing the ANIP fundamentals
According to ANI Pharmaceuticals Inc [NASDAQ:ANIP], the company’s sales were 674.07M for trailing twelve months, which represents an 43.43% jump. Gross Profit Margin for this corporation currently stands at 0.57% with Operating Profit Margin at 0.01%, Pretax Profit Margin comes in at -0.04%, and Net Profit Margin reading is -0.03%. To continue investigating profitability, this company’s Return on Assets is posted at -0.02, Equity is -0.05 and Total Capital is 0.01. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.76.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 64.55 points at the first support level, and at 62.49 for the second support level. However, for the 1st resistance point, the stock is sitting at 67.71, and for the 2nd resistance point, it is at 68.81.
Ratios To Look Out For
It is important to note that ANI Pharmaceuticals Inc [NASDAQ:ANIP] has a current ratio of 2.66. On the other hand, the Quick Ratio is 1.98, and the Cash Ratio is 0.74. Considering the valuation of this stock, the price to sales ratio is 2.14, the price to book ratio is 3.45.
Transactions by insiders
Recent insider trading involved Cook Meredith, SR. VP, GENERAL COUNSEL & SEC., that happened on Jul 14 ’25 when 400.0 shares were sold. SR. VP, GENERAL COUNSEL & SEC., Cook Meredith completed a deal on Jun 13 ’25 to sell 400.0 shares. Meanwhile, SVP, GENERICS Gutwerg Ori sold 881.0 shares on May 15 ’25.
